History
  • No items yet
midpage
Hill Dermaceuticals, Inc. v. Food & Drug Administration
404 U.S. App. D.C. 214
| D.C. Cir. | 2013
Read the full case

Background

  • Hill Dermaceuticals filed NDA for Derma-Smoothe corticosteroid in 1988 (three formulations).
  • In 2011 the FDA approved three Identi ANDAs for generic versions of Hill’s products.
  • Hill alleged FDA approvals were arbitrary and capricious under the APA; district court granted summary judgment for FDA.
  • FDA waived bioequivalence data under 21 C.F.R. § 320.22(b)(3) for body/scalp oil and § 320.24(b)(6) for ear drops.
  • Appellate review focused on whether waivers were proper and whether labeling differences violated the same-labeling requirement.
  • Court affirms district court’s grant of summary judgment for FDA; agency actions not arbitrary or capricious.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Extra-record evidence properly considered? Hill argues district court should have reviewed extra-record declarations. Agency record sufficiency dictates review; extra-records not allowed. Not error; no substantial question of procedural validity.
Propriety of bioequivalence waivers? Waivers were improper; products not true solutions under 320.22(b)(3). Waivers appropriate; evidence shows solutions and no material differences. Waivers upheld; FDA reasonable.
Scalp/oil labeling disparity's effect on waiver? Different testing for scalp labeling undermines fairness. Waiver rationale governs; scalp testing differences not dispositive. Waiver supported; labeling differences not fatal.
Labeling requirement under same-labeling provision? Identi’s labeling differs from Hill’s; not “the labeling approved for the listed drug.” Hill’s method not validated; USP-NF refinement suffices; exception allows labeling changes. Not arbitrary; FDA labeling approach permissible.

Key Cases Cited

  • Walter O. Boswell Mem’l Hosp. v. Heckler, 749 F.2d 788 (D.C. Cir. 1984) (courtistates exact record to review must mirror agency’s record)
  • Es ch v. Yeutter, 876 F.2d 976 (D.C. Cir. 1989) (extra-record evidence limited to serious procedural questions)
  • Theodore Roosevelt Conservation P’ship v. Salazar, 616 F.3d 497 (D.C. Cir. 2010) (limits on using extra-record evidence; defers to agency findings)
  • Bennett v. Donovan, 703 F.3d 582 (D.C. Cir. 2013) (APA review remand preferred where legal error identified)
Read the full case

Case Details

Case Name: Hill Dermaceuticals, Inc. v. Food & Drug Administration
Court Name: Court of Appeals for the D.C. Circuit
Date Published: Mar 12, 2013
Citation: 404 U.S. App. D.C. 214
Docket Number: 12-5182
Court Abbreviation: D.C. Cir.